Back to Journals » Cancer Management and Research » Volume 12

ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway

Total article views   HTML views PDF downloads Totals
6,084 Dovepress* 5,489+ 951 6,440
PubMed Central* 595 178 773
Totals 6,084 1,129 7,213
*Since 14 January 2020

View citations on PubMed Central and Google Scholar